Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Intercept Pharma Danmark ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2014 N/A 2015 N/A 2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020e N/A 2021e N/A Bankruptcy risk for industry   1.1% 1.1% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   0.0% 0.0% 17.1% 12.8% 9.9% 4.5% 18.0% 18.0%   Credit score (0-100)   0 0 12 20 26 48 8 7   Credit rating   N/A N/A BB BB BB BBB B B   Credit limit (kDKK)   0.0 0.0 -0.0 -0.0 -0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2014 N/A 2015 N/A 2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020e N/A 2021e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   0.0 0.0 -9,118 -9,178 1,001 2,804 0.0 0.0   EBITDA   0.0 0.0 -23,656 -25,873 -7,085 406 0.0 0.0   EBIT   0.0 0.0 -23,656 -25,873 -7,085 406 0.0 0.0   Pre-tax profit (PTP)   0.0 0.0 -23,656.0 -25,789.0 -7,148.0 80.8 0.0 0.0   Net earnings   0.0 0.0 -23,656.0 -25,789.0 -7,148.0 -27.2 0.0 0.0   Pre-tax profit without non-rec. items   0.0 0.0 -23,656 -25,789 -7,148 80.8 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2014 N/A 2015 N/A 2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020e N/A 2021e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   0.0 0.0 -23,606 -31,719 -38,867 -38,894 -38,944 -38,944   Interest-bearing liabilities   0.0 0.0 21,385 32,716 46,286 48,455 38,944 38,944   Balance sheet total (assets)   0.0 0.0 879 6,931 8,426 9,721 0.0 0.0   Net Debt   0.0 0.0 20,543 26,544 43,509 48,416 38,944 38,944     See the entire balance sheet 1000.0 Volume  2014 N/A 2015 N/A 2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020e N/A 2021e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   0.0 0.0 -9,118 -9,178 1,001 2,804 0.0 0.0   Gross profit growth   0.0% 0.0% 0.0% -0.7% 0.0% 180.1% -100.0% 0.0%   Employees   0 0 5 5 5 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% -80.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0 0 879 6,931 8,426 9,721 0 0   Balance sheet change%   0.0% 0.0% 0.0% 688.5% 21.6% 15.4% -100.0% 0.0%   Added value   0.0 0.0 -23,656.0 -25,873.0 -7,085.0 406.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   0.0 0.0 -1.0 -2.0 -3.0 1.0 0.0 0.0   1000.0 Profitability  2014 N/A 2015 N/A 2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020e N/A 2021e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 0.0% 259.4% 281.9% -707.8% 14.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.0% 0.0% -96.6% -81.7% -16.5% 0.8% 0.0% 0.0%   ROI %   0.0% 0.0% -110.6% -95.3% -17.9% 0.9% 0.0% 0.0%   ROE %   0.0% 0.0% -2,691.2% -660.4% -93.1% -0.3% 0.0% 0.0%   1000.0 Solidity  2014 N/A 2015 N/A 2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020e N/A 2021e N/A Equity ratio %   0.0% 0.0% -96.4% -82.1% -82.2% -80.0% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% 0.0% -86.8% -102.6% -614.1% 11,924.6% 0.0% 0.0%   Gearing %   0.0% 0.0% -90.6% -103.1% -119.1% -124.6% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% -0.0% 0.0% 0.2% 0.7% 0.0% 0.0%   1000.0 Liquidity  2014 N/A 2015 N/A 2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020e N/A 2021e N/A Quick Ratio   0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0   Current Ratio   0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0   Cash and cash equivalent   0.0 0.0 842.0 6,172.0 2,777.0 39.1 0.0 0.0   1000.0 Capital use efficiency  2014 N/A 2015 N/A 2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020e N/A 2021e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   0.0 0.0 -23,643.0 -31,756.0 -38,904.0 -38,937.9 -19,472.0 -19,472.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2014 N/A 2015 N/A 2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020e N/A 2021e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 -4,731 -5,175 -1,417 406 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 -4,731 -5,175 -1,417 406 0 0   EBIT / employee   0 0 -4,731 -5,175 -1,417 406 0 0   Net earnings / employee   0 0 -4,731 -5,158 -1,430 -27 0 0